Atlas Trials

The Role of N-acetyl-l-cysteine (NAC) as an Adjuvant to Opioid Treatment in Patients With Chronic Neuropathic Pain

Clinical trial NCT01840345 · COMPLETED

Trial details

NCT number
NCT01840345
Sponsor
Virginia Commonwealth University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Neuropathic Pain
Start date
2014-01-01
Primary completion
2017-03-01
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.